B+
Bull case
25%
Probability
Target price
$255.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
RMD
ResMedCNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The earnings follow-up strengthens the constructive case: Q4 revenue and adjusted EPS modestly exceeded stored pre-print expectations, while full-year margins, cash generation, product launches, and shareholder returns remained supportive. MatrixCare's sale may improve portfolio focus [#SEC-8K-2026-08-06].
Posture
Mixed
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-10-28.
What can break
MatrixCare closing remains subject to regulatory approvals and customary conditions, with financial impact still uncertain [#SEC-8K-2026-07-07].
Momentum
73
Value
58
Sentiment
45
Setup hits (3d)
6 · Net Bullish
AI TargetsBase $230.00 · Bull $255.00 · Bear $185.00Analysis 2026-08-08; returns require an exact persisted reference.
Earnings
2026-10-29 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-28
Investment thesis
As of 2026-10-28
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $263.01
Why
Momentum73 · Δ7d +16.3
Value58 · Δ7d -0.1
Sentiment45 · Δ7d -1.3
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 6 setup hits (3d) with net bullish as of 2026-10-28.
- • Next scheduled catalyst: earnings 2026-10-29 · AMC.
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • MatrixCare closing remains subject to regulatory approvals and customary conditions, with financial impact still uncertain [#SEC-8K-2026-07-07].
- • Q4 GAAP gross-margin and operating-margin contraction despite stronger non-GAAP margins [#SEC-8K-2026-08-06].
- • The print was not uniformly clean: Q4 GAAP gross margin declined 200 bps, GAAP operating margin declined 300 bps, operating cash flow fell 16%, and free cash flow fell 21% year over year.
Catalyst clock
2026-10-29 · AMC
FY2026 Q4 results modestly exceeded stored pre-print expectations
Lead driver: Value · See fundamentals
Momentum
73
8% active weight
Current posture
7d trendFlat
Δ7d
+16.3
Δ21d
+19.9
Value
58
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-1.2
Sentiment
45
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
-19.4
Why this grade
Composite grade C. Momentum 73.2 / Value 58.3 / Sentiment 44.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-08. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$230.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$185.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$35.27B
Beta
0.87
Shares Out
140.64M
P/E (TTM)
25.1
P/S (TTM)
6.81
P/FCF (TTM)
24.94
Rev YoY
+8.6%
EPS YoY
+2.4%
Gross Margin
+60.3%
Op Margin
+34.0%
Net Debt
-$646.67M
Current Ratio
3.10
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data